Literature DB >> 360797

BCG in tumor immunotherapy.

R W Baldwin, M V Pimm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 360797     DOI： 10.1016/s0065-230x(08)60647-8

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  19 in total

1.  Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability.

Authors:  C A Brown; I N Brown; V S Sljivić
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

Review 2.  Manipulation of host resistance in cancer therapy.

Authors:  R W Baldwin
Journal:  Springer Semin Immunopathol       Date:  1982

3.  The immunopathological effects of intracolonic injection of Mycobacterium bovis BCG cell wall emulsions in guinea pigs.

Authors:  G L Cockerell; R W O'Donnell; M M Zgola
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Menningococcal antigens (MA): a novel immune stimulant in experimental neoplasia.

Authors:  J A Teodorczyk-Injeyan; B G Sparkes; J M Dupuy; V V Micusan; R E Falk
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

5.  Augmentation of antitumor resistance by a strain of unicellular green algae, Chlorella vulgaris.

Authors:  K Tanaka; F Konishi; K Himeno; K Taniguchi; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

6.  Inhibition of tumor growth in mice treated with synthetic muramyl dipeptide.

Authors:  J Bubeník; J Jezek; M Zaoral; J Hofmann; Y V Gruntenko; J G Osipov; A G Zolotareva; T E Vakhrusheva; V G Budker
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  BCG, Corynebacterium parvum or Mycobacterium leprae added to cultures of BCG-primed mouse spleen cells cause an enhanced primary antibody response in vitro.

Authors:  C A Brown; I N Brown; V S Sljivić
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

8.  Immunological approaches to cancer treatment.

Authors:  R W Baldwin
Journal:  Jpn J Surg       Date:  1980-03

9.  Inhibition of spontaneous pulmonary metastases of Lewis lung carcinoma by oral treatment with Respivax and Broncho-Vaxom.

Authors:  K T Kassabov; J N Stoychkov
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

10.  Studies on the antitumor activities of pyrimidinone-interferon inducers. Part 2. Potentiation of antitumor resistance mechanisms.

Authors:  L Milas; N Hunter; H Ito; E Lotzová; D A Stringfellow
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.